Lithium Aspartate 5 mg

Lithium Aspartate 5 mg

Solaray4.7 (1,347 ratings)
Format:Capsule Quantity: 100 VegCap(s) · 100 servings
Goals
$11.59 $0.11 per serving

Product analysis

85 out of 100

Lithium Aspartate 5 mg is aimed at mood support, but benefits from prescription lithium cannot be assumed for this low-dose supplement.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality80

Lithium aspartate has a clearly identified, reasonably favorable form comparison. That does not establish that the low-dose serving improves mood.

Ingredient Transparency100

The lithium amount and form are clearly stated. That makes the serving easy to compare with other lithium supplements.

Value For Money80

The serving price offers favorable value for lithium aspartate. A low price does not establish a mood benefit.

Customer Satisfaction82

Customer feedback is very positive across a substantial number of ratings. That indicates broad satisfaction without confirming mood improvement.

Product Focus82

The single-ingredient formula has a clear mood-focused purpose. Mood benefits at this supplement amount remain unestablished because prescription lithium findings do not transfer to it.

Format
Capsule
Container
100 VegCap(s)
Per serving
$0.11
Customer rating
4.7 · 1,347 ratings
Report analysis

Goals

Mood Support
Impact
Highest effect
A+ Ingredient FitC- PathwaysB+ EvidenceA+ Formulation Logic

Lithium has clinical mood-treatment evidence at prescription exposures, but that evidence cannot be transferred to this 5 mg supplement serving. The supplied information does not establish mood improvement from trace lithium or lithium aspartate. Recognition of the amount and preparation in the saved comparison does not resolve that difference.

How this product is rated for Mood Support

Ingredient fit100

Lithium provide the recorded ingredient connection. The declared amounts reach the saved comparison’s reference range; this does not establish an effective mood dose.
Goal fit
The relevant ingredients give this formula a clear connection to mood support, subject to their individual limitations.
Dose adequacy
The declared amounts reach the saved comparison’s reference range; this does not establish an effective mood dose.

Pathways56

The strongest recorded connection is neuroinflammation and neuroplasticity, without establishing a corresponding improvement in mood.
Depth
The strongest recorded connection is neuroinflammation and neuroplasticity, without establishing a corresponding improvement in mood.
Breadth
The recorded contribution is concentrated in one functional area, rather than broad mood support.

Evidence82

The leading ingredient is recognized in the saved findings, but its population and outcome limitations constrain expectations for general mood support.
Evidence strength
The leading ingredient is recognized in the saved findings, but its population and outcome limitations constrain expectations for general mood support.
Studied preparation
The saved findings recognize the declared preparations; this does not establish interchangeable extracts or routine mood benefit.

Formulation logic100

The supplied facts show no configured conflicts or missing required partners. Amount thresholds describe the saved comparison, rather than proven mood efficacy.
Partner coverage
The recognized ingredients do not lack a required partner in the supplied findings; this does not establish added benefit from combining them.
Conflicts
No configured ingredient conflict was identified in the supplied facts.
Effective doses
All counted ingredients meet the saved amount threshold, which is not a proven effective mood dose.
Study evidence
Lithium Supportive 197 studies

Ingredients

IngredientAmount per servingScore
Lithium (Lithium Aspartate)
5 mg 88
Adults 18–50 Women
Report overview
B+ Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyB+ Value
A serving provides 5 mg of lithium from lithium aspartate. The whole-product serving costs about $0.12.
How this ingredient is rated

Active Ingredient Quality & Bioavailability80

Lithium Aspartate is the named chemical form; the saved information does not establish that it is absorbed better than other forms.
Lithium Compound Optimization
Lithium Aspartate is the named chemical form; the saved information does not establish that it is absorbed better than other forms.

Dose, Safety & Label Transparency100

The stated 5 mg per serving is the amount of lithium itself, making it possible to compare with other amounts given on the same basis.
Elemental Disclosure Precision
The amount of lithium itself is stated as 5 mg per serving, rather than only the weight of its source compound.
Dosage Appropriateness
A serving contains 5 mg of lithium.

Value80

The whole-product serving costs about $0.12 and supplies 5 mg of lithium.
Cost Per Serving Efficiency
The whole-product serving costs about $0.12 and supplies 5 mg of lithium.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.
    Yatham LN; Kennedy SH; Parikh SV; Schaffer A; Bond DJ; Frey BN; Sharma V; Goldstein BI; Rej S; Beaulieu S; Alda M; MacQueen G; Milev RV; Ravindran A; O'Donovan C; McIntosh D; Lam RW; Vazquez G; Kapczinski F; McIntyre RS; Kozicky J; Kanba S; Lafer B; Suppes T; Calabrese JR; Vieta E; Malhi G; Post RM; Berk M · Bipolar disorders · 2019
    Guideline / consensusMood Support forLithium
  2. GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients With Bipolar Disorder.
    Young RC; Mulsant BH; Sajatovic M; Gildengers AG; Gyulai L; Al Jurdi RK; Beyer J; Evans J; Banerjee S; Greenberg R; Marino P; Kunik ME; Chen P; Barrett M; Schulberg HC; Bruce ML; Reynolds CF; Alexopoulos GS; GERI-BD Study Group · The American journal of psychiatry · 2017
    Randomized trial224 participantsMood Support forLithium
  3. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
    Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J; Lamictal 606 Study Group · Archives of general psychiatry · 2003
    Randomized trial175 participantsMood Support forLithium
  4. Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials.
    Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Mishima K; Iwata N · Molecular psychiatry · 2022
    Meta-analysis9,821 participants41 studies pooledMood Support forLithium
  5. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.
    Goodwin GM; Bowden CL; Calabrese JR; Grunze H; Kasper S; White R; Greene P; Leadbetter R · The Journal of clinical psychiatry · 2004
    Meta-analysis638 participants2 studies pooledMood Support forLithium